Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Dec 29, 2020

Philippines Bans Travelers From 20 Nations With New Strain

STOCKS IN THIS STORY
Goenka Business & Finance Ltd.
--
Cosco (India) Ltd.
--
USD-INR
--
MSCI World
--
Pritika Auto Industries Ltd
--
Cons Discretionary Goods & Serv
--
SAB Events & Governance Now Media Ltd.
--
MSCI AC Asia ex-Japan
--
BSE Healthcare
--
International Travel House Ltd.
--
Advance Lifestyles Ltd.
--
MMTC Ltd.
--

The Philippines has decided to ban travelers from 20 nations with the new Covid-19 strain, Labor Secretary Silvestre Bello said Tuesday.

The travel ban covers Australia, Canada, China, Denmark, France, Germany, Iceland, Ireland, Israel, Italy, Japan, Lebanon, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, The Netherlands, and the U.K., Bello said.

The ban will be effective December 30 to January 15, and applies only to Hong Kong and not the whole of China, presidential spokesman Harry Roque said in a separate briefing.

Filipino workers returning from these countries are exempted from the ban, said the labor chief, who expects as many as 100,000 more repatriates. The new strain hasn't been detected in the Philippines, according to the Department of Health.

Philippines Warns of Unapproved Covid Shots as Soldiers Get Jabs

Daily infections rose by 886 on Tuesday, the third straight day when the new case count is below 1,000 as testing also falls below target. With total of more than 471,000, the Philippines has the second highest cases in southeast Asia, next only to Indonesia.

The Philippines has approved Janssen Pharmaceuticals Inc.'s application to conduct a clinical trial of its coronavirus vaccine in the Southeast Asian nation, Food and Drug Administration Director General Eric Domingo said earlier Tuesday.

“In the next few weeks, we will be able to begin clinical trials,” Domingo said. The trial applications of Chinese firms Sinovac Biotech Ltd. and Sichuan Clover Biopharmaceuticals Inc., and Pfizer Inc.'s application for emergency use for its vaccine are still under review, he said.

©2020 Bloomberg L.P.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search